19Apr 2021
A novel KLHL6/KLHL24 intergenic region-NTRK3 fusion in a patient with lung squamous cell carcinoma

A novel KLHL6/KLHL24 intergenic region-NTRK3 fusion in a patient with lung squamous cell carcinoma

NTRK (neurotrophic tyrosine receptor kinase) fusions have been identified as new targetable driver oncogene of cancer therapy, which are found in approximately 0.2%–3.3% non-small-cell lung cancer (NSCLC). As next-generation sequencing (NGS) has been widely used for fusion detection, more intergenic-breakpoint fusions are found and functional fusion transcripts can bring target clinical benefit...

  • #pulmonology

Like

Save

Share